NIVF
NEWGENIVF-A (NIVF)
NASDAQ
$0.87+$0.03 (+3.19%)
Price as of Jun 03, 2026 7:47 PM EDT
  • $517,373.00
    Market Cap
  • -99.92%
    1-Year Change
  • Medical Care Facilities
    Industry
Annual
Quarterly
12/31/2025
12/31/2024
12/31/2023
Income Statement
Total Operating Revenue
4.7M
-13.01%
5.4M
+5.79%
5.1M
N/A
Cost of Revenue
3.8M
+4.55%
3.6M
+4.40%
3.5M
N/A
Gross Profit
955,846
-47.68%
1.8M
+8.63%
1.7M
N/A
Sales and Marketing Expense
1.2M
+476.17%
206,314
+1,044.28%
18,030
N/A
Research and Development Expense
N/A
N/A
N/A
N/A
N/A
N/A
Depreciation and Amortization Expense
188,109
+864.56%
19,502
-37.44%
31,173
N/A
Total Operating Expenses
11.7M
+291.05%
3.0M
+82.21%
1.6M
N/A
Operating Profit
-10.7M
+824.30%
-1.2M
-2,847.25%
42,242
N/A
Interest Income
2,251
-67.63%
6,953
+1,242.28%
518
N/A
Interest Expense
-616,423
-20.84%
-778,656
+1,586.17%
-46,179
N/A
Interest Income and Expense and Net
-614,172
-20.41%
-771,703
+1,590.07%
-45,661
N/A
Total Nonoperating Income and Expense
20.5M
+10,143.57%
199,688
+201.75%
66,176
N/A
Income before Taxes
9.7M
+1,112.56%
-960,807
-986.21%
108,418
N/A
Income Taxes
N/A
N/A
-486,706
N/A
N/A
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
9.9M
+1,983.07%
-524,643
-502.97%
130,193
N/A
Net Income from Continuing Operations Applicable to Common
9.7M
+1,112.56%
-960,807
-986.21%
108,418
N/A
Basic EPS and Net Income
214.73
+16,367.42%
-1.32
-833.33%
0.18
N/A
Diluted EPS and Net Income
3.04
+575.00%
-0.64
-455.56%
0.18
N/A
Basic Weighted Average Shares
46,009
-87.15%
358,108
-41.78%
615,135
N/A
Diluted Weighted Average Shares
3.3M
+337.23%
743,323
+20.84%
615,135
N/A
Balance Sheet
Cash and Cash Equivalents
758,621
+65.73%
457,740
+746.04%
54,104
N/A
Short-Term Investments
N/A
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
758,621
+65.73%
457,740
+746.04%
54,104
N/A
Total Current Assets
7.4M
+132.72%
3.2M
+164.08%
1.2M
N/A
Accumulated Depreciation
1.2M
-0.89%
1.2M
-6.06%
1.3M
N/A
Property and Plant and Equipment and Net
1.8M
+555.12%
273,096
+68.41%
162,157
N/A
Total Long-Term Assets
25.3M
+6,156.61%
404,999
-9.19%
446,004
N/A
Total Assets
32.7M
+814.62%
3.6M
+117.17%
1.6M
N/A
Income Taxes Payable
1,889
-83.92%
11,746
-97.59%
486,706
N/A
Total Short-Term Debt
256,056
+210.57%
82,447
N/A
N/A
N/A
Total Current Liabilities
2.4M
-13.01%
2.7M
+142.36%
1.1M
N/A
Total Long-Term Debt
4.1M
+75.93%
2.3M
+263.31%
641,025
N/A
Total Long-Term Liabilities
4.4M
+86.81%
2.3M
+1,866.02%
118,979
N/A
Total Liabilities
6.7M
+33.14%
5.1M
+307.55%
1.2M
N/A
Retained Earnings
8.9M
+1,001.97%
-985,994
+113.72%
-461,351
N/A
Total Stockholders Equity
26.6M
+2,639.69%
-1.0M
-217.02%
896,076
N/A
Total Shares Outstanding
240,622
-78.87%
1.1M
+63.08%
698,123
N/A
Cash Flow
Cash from Operating Activities
-10.9M
+32.21%
-8.3M
+367.92%
-1.8M
N/A
Capital Expenditures
135,025
+154.55%
53,045
-24.06%
69,848
N/A
Cash from Investing Activities
-7.6M
+14,151.62%
-53,045
-24.06%
-69,848
N/A
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
19.0M
+118.92%
8.7M
+361.11%
1.9M
N/A
Financials Ratio
Gross Margin
20.22%
-39.85%
33.62%
N/A
N/A
N/A
Operating Margin
-226.95%
+962.55%
-21.36%
N/A
N/A
N/A
Return on Assets
54.43%
+371.06%
-20.08%
N/A
N/A
N/A
Return on Equity
77.23%
-88.77%
687.89%
N/A
N/A
N/A
Revenue Growth
-13.01%
-324.84%
5.79%
N/A
N/A
N/A
Current Ratio
3.12
+167.53%
1.17
N/A
N/A
N/A
Cash Ratio
0.32
+90.49%
0.17
N/A
N/A
N/A
Debt-to-Equity Ratio
0.16
+107.11%
-2.30
N/A
N/A
N/A
Debt-to-Assets Ratio
0.13
-80.27%
0.67
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow